Asset Details
Do you wish to reserve the book?
Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Do you wish to request the book?
Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Phenotypic Spectrum of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
2013
Overview
Glut1 deficiency syndrome (Glut1 DS) was originally described in 1991 as a developmental encephalopathy characterized by infantile onset refractory epilepsy, cognitive impairment, and mixed motor abnormalities including spasticity, ataxia, and dystonia. The clinical condition is caused by impaired glucose transport across the blood brain barrier. The past 5 years have seen a dramatic expansion in the range of clinical syndromes that are recognized to occur with Glut1 DS. In particular, there has been greater recognition of milder phenotypes. Absence epilepsy and other idiopathic generalized epilepsy syndromes may occur with seizure onset in childhood or adulthood. A number of patients present predominantly with movement disorders, sometimes without any accompanying seizures. In particular, paroxysmal exertional dyskinesia is now a well-documented clinical feature that occurs in individuals with Glut1 DS. A clue to the diagnosis in patients with paroxysmal symptoms may be the triggering of episodes during fasting or exercise. Intellectual impairment may range from severe to very mild. Awareness of the broad range of potential clinical phenotypes associated with Glut1 DS will facilitate earlier diagnosis of this treatable neurologic condition. The ketogenic diet is the mainstay of treatment and nourishes the starving symptomatic brain during development.
Publisher
Current Science Inc,Springer Nature B.V
Subject
/ Anticonvulsants - therapeutic use
/ Ataxia
/ Brain Diseases, Metabolic, Inborn - complications
/ Brain Diseases, Metabolic, Inborn - genetics
/ Brain Diseases, Metabolic, Inborn - metabolism
/ Dystonia
/ Dystonic Disorders - genetics
/ Epilepsy
/ Epilepsy - prevention & control
/ Genotype
/ Glucose
/ Glucose Transporter Type 1 - deficiency
/ Glucose Transporter Type 1 - genetics
/ Glucose Transporter Type 1 - physiology
/ Humans
/ Intellectual Disability - genetics
/ Language Disorders - genetics
/ Medicine
/ Movement Disorders - genetics
/ Muscle Spasticity - genetics
/ Mutation
